Drug
Ebastine clinical trials
- studies test it
- 7
- open now
- 3
- in phase 3
- 2
- first study started
- 2009
Keep track of what changes. Save the ebastine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2013 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
KU Leuven (2) · Guy Boeckxstaens (1) · Grupo de Alergología Clínica y Experimental (1) · Second Affiliated Hospital of Xi'an Jiaotong University (1) · Md. Hazrat Ali (1) · Rigshospitalet, Denmark (1)
Often tested with
Tested in the same studies.
Cetirizine (1) · Desloratadine (1) · Fexofenadine (1) · Bilastine (1) · Docetaxel (1)
Studies
Open first, then newest update. How each study uses ebastine is read from its arms, and is right about nine times in ten.
Testing it · 7
- Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After SurgeryNot yet recruitingPhase 4Second Affiliated Hospital of Xi'an Jiaotong UniversityNCT07734766Written as Ebastine
- Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel SyndromeRecruitingPhase 2/3Md. Hazrat AliNCT07114055Written as ebastine
- Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate CancerRecruitingPhase 1/2Rigshospitalet, DenmarkNCT06480110Written as Docetaxel + Ebastine
- Ebastine Versus Mebeverine in IBS PatientsActive, not recruitingPhase 3Guy BoeckxstaensNCT05815602Written as Ebastine
- Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter TrialCompletedPhase 4KU LeuvenNCT01908465Written as Ebastine
- Irritable Bowel Syndrome (IBS) Treatment With H1-receptor AntagonistsCompletedPhase 4KU LeuvenNCT01144832Written as ebastine
- Evaluation of the Inhibitory Effect of 5 Anti-Histamines in UrticariaCompletedPhase 4Grupo de Alergología Clínica y ExperimentalNCT01940393Written as Ebastine
Codes
What other systems call ebastine · ClinicalTrials.gg INT003409
- MeSH (NLM) C058249ebastineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) TQD7Q784P1EBASTINEConfirmed FDA, NLM, Wikidata
- RxNorm 23796Confirmed FDA, Wikidata
- Wikidata Q2327739ebastineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C77437EbastineOne source FDA
- DrugBank DB11742One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C058249 | ebastine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | TQD7Q784P1 | EBASTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 23796 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2327739 | ebastine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C77437 | Ebastine | One source FDA |
| DrugBank | DB11742 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.